Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Homeowners Choice Announces Follow-on Public Offering Of 1.60 Mln Shares

RELATED NEWS
Trade HCI now with 

Homeowners Choice, Inc. (HCII: Quote), a Florida-based insurance holding company, announced a follow-on public offering of 1.60 million shares of common stock. All shares are being offered by Homeowners Choice. Homeowners Choice said that it intends to use the net proceeds from this offering for working capital and general corporate purposes.

Houlihan Lokey Capital, Inc. and Sidoti & Co. LLC are acting as joint book-running managers for the offering. Knight Capital Americas, L.P. is acting as co-manager. The underwriters will have an option to purchase up to an additional 240,000 shares of common stock from the Company.

Click here to receive FREE breaking news email alerts for HCI Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.